Skip to main content
SpringerLink
Log in

Complications of post-transplant immunosuppression: cancer and diabetes

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Penn I. Malignancy after immunosuppressive therapy: how can the risk be reduced? Clin Immunother 1995 Sep; 4(3): 207–18

    Article  Google Scholar 

  2. Krentz AJ, Dmitrewski J, Mayer D, et al. Effects of immunosuppressive agents on glucose metabolism: implications for the development of post-transplant diabetes mellitus. Clin Immunother 1995 Aug; 4(2): 103–23

    Article  Google Scholar 

  3. Sheil AGR, Disney APS, Mathew TH, et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993 Feb; 25(1): 1383–4

    Google Scholar 

  4. Frei U, Bode H, Repp R, et al. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period. Transplant Proc 1993 Feb; 25(1): 1394–6

    PubMed  CAS  Google Scholar 

  5. Patcheil RA. Neurological complications of organ transplant. Ann Neurol 1994 Nov; 36: 688–703

    Article  Google Scholar 

  6. Penn I. De novo tumors in pediatric organ transplant recipients. Transplant Proc 1994 Feb; 26(1): 1–2

    PubMed  CAS  Google Scholar 

  7. Tacrolimus: heir apparent to the post-transplant immunosuppression throne? Drug Ther Perspect 1994 Apr 18; 3(7): 1–5

  8. Mycophenolate mofetil: complementary immunosuppressant action. Drug Ther Perspect 1994 Jul 25; 4(2): 7–8

  9. Levy M, Backman L, Husberg B, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993 Feb; 25(1): 1397–9

    PubMed  CAS  Google Scholar 

  10. McAlister V, Grant D, Roy A, et al. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. Transplant Proc 1993 Feb; 25(1): 1400–1

    PubMed  CAS  Google Scholar 

  11. Gruber SA, Gillingham K, Sothern RB, et al. Cancer development in pediatric primary renal allograft recipients. Transplant Proc 1994 Feb; 26(1): 3–4

    PubMed  CAS  Google Scholar 

  12. Sheil AGR, Disney APS, Mathew TH, et al. Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA. Transplant Proc 1991 Feb; 23(1): 1111–2

    PubMed  CAS  Google Scholar 

  13. Individualise therapy for AIDS-related Kaposi’s sarcoma. Drug Ther Perspect 1995 Jul 24; 6(2): 5–10

    Google Scholar 

  14. Wingen A-M, Wiesel M, Möhring K, et al. Malignancies in children with renal replacement therapy. Transplant Proc 1994 Feb; 26(1): 5–6

    PubMed  CAS  Google Scholar 

  15. Cancers following organ transplantation. WHO Drug Information 1991; 5(2): 56

    Google Scholar 

  16. Tan-Shalaby J, Tempero M. Malignancies after liver transplantation: a comparative review. Semin Liver Dis 1995; 15(2): 156–64

    Article  PubMed  CAS  Google Scholar 

  17. Jindal RM. Posttransplant diabetes mellitus — a review. Transplantation 1994 Dec 27; 58(12): 1289–98

    PubMed  CAS  Google Scholar 

  18. Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients. Drug Saf 1995 Sep; 13(3): 145–56

    Article  PubMed  CAS  Google Scholar 

  19. Tabasco-Minguillan J, Mieles L, Carroll P, et al. Insulin requirements after liver transplantation an FK506 immunosuppression. Transplantation 1993; 56: 862

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Complications of post-transplant immunosuppression: cancer and diabetes. Drugs Ther. Perspect 7, 13–16 (1996). https://doi.org/10.2165/00042310-199607030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607030-00005

Search

Navigation